Novel therapeutic targets for appetite regulation.
Obesity is currently the major cause of premature death in the UK, killing almost 1000 individuals per week, and worldwide, its prevalence is accelerating. Many peptides are synthesized and released from the gastrointestinal tract and, while their roles in the regulation of gastrointestinal function have been known for some time, it is now evident that they also physiologically influence eating behavior. Therefore, manipulation of gastrointestinal hormones provides the prospect of an effective and well-tolerated treatment for obesity. Whereas drugs targeting appetite-signaling neuropeptides in the brain may also affect other aspects of the central nervous system, agents based on gut hormones themselves have the advantage of targeting specific appetite circuits within the brain without producing any unacceptable side effects.
Small
Caroline J
CJ
Department of Metabolic Medicine, Division of Investigative Science, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 ONN, UK.
Parkinson
James R
JR
Bloom
Stephen R
SR
D001069:Appetite Regulation / Q000187:drug effects* / Q000502:physiology*; D016503:Drug Delivery Systems / Q000639:trends*; D006801:Humans; D009765:Obesity / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology